glp glp 1 Glucagon-like peptide in health and disease GLP-1 and Anesthesia: Considerations and

In our experience, transitioning directly to subcutaneous semaglutide 1 mg once weekly from another GLP-1 receptor agonist can be associated with nausea or GI disturbance

The relative importance of GIP and GLP-1 may vary depending on meal composition and diabetes stages

Within the GLP-1 receptor agonist class , other options available in the UK include: Dulaglutide (Trulicity) weekly injection with proven cardiovascular benefits [12] [17] Liraglutide (Victoza) daily injection with proven cardiovascular benefits [13] Exenatide (Byetta) twice-daily injection Exenatide extended-release (Bydureon) weekly injection Lixisenatide (Lyxumia) daily injection Tirzepatide (Mounjaro) weekly injection that acts on both GLP-1 and GIP receptors [14] [15] Whilst these medications share similar mechanisms to semaglutide, individual tolerability varies

This suggests a more direct effect on CSF dynamics, potentially via GLP-1 receptors in the choroid plexus that may influence CSF production

QianKeHeJiChu ZK (2024) General 123) awarded to BX, National Natural Science Foundation Cultivation Project (Grant No

Managing bloating with fiber If bloating is your primary concern, fiber selection becomes even more critical